11 ms·
> Then the medicine would need to be 100x [300x-400x] more expensive than the vaccine I'm not suggesting this is true, but it would need to be 100x-400x more p
by xscott 5y ago
> Then the medicine would need to be 100x [300x-400x] more expensive than the vaccine
I'm not suggesting this is true, but it would need to be 100x-400x more profitable, and that includes cost to make and store as well as the price is charged.
Maybe making mRNA vaccines costs much more than a simpler molecule like Paxlovid [0], and hospitals generally seem to charge much more than the over the counter price for everything. You've seen horror stories about $25 aspirin [1] which is easily 400x more expensive than the penny per pill cost of 500 tablets in a $5 bottle [2].
[0] https://en.wikipedia.org/wiki/Nirmatrelvir https://en.wikipedia.org/wiki/Nirmatrelvir
[1] https://www.healthcarefinancenews.com/blog/why-aspirin-taken-hospital-can-cost-upwards-25 https://www.healthcarefinancenews.com/blog/why-aspirin-taken...
[2] https://amazon.com/Basic-Care-Aspirin-Regular-Strength/dp/B0779D4BTN https://amazon.com/Basic-Care-Aspirin-Regular-Strength/dp/B0...
- fileeditview 5y agoThis is what i meant (profitable). Sorry bad translation. However their vaccine research was highly funded by states (at least here in Germany and I suspect everywhere else too) so.. not sure how easy it would be to calculate all of that.
- xscott 5y agoThat's another subtlety. They've already been funded to make the mRNA vaccine, so maybe that has been milked dry and it's time to move on to the next profitable cow. Obviously I'm just speculating that it's possible.